Osteoarthritis and Associated Pain: Molecular Research and Novel Therapeutic Approaches, 2nd Edition
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 172
Special Issue Editor
Interests: osteoarthritis; pain; depression
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Osteoarthritis (OA), the most common form of arthritis, is a leading cause of debilitating pain and disability, affecting more than 32 million people in the US. The prevalence and incidence of OA have been continuously increasing due to increases in lifespan and obesity.
This Special Issue aims to present evidence of the potential targets, therapeutic drugs, and nanoformulations, and their mechanisms in treating osteoarthritis and associated pain. We welcome original research and review papers focused on the mechanisms and therapeutic potential of phytochemicals, peptides, and synthetic nanoparticle-based formulations that are engaged in improving osteoarthritic pain in preclinical and clinical studies. Furthermore, we encourage studies using in vivo and in vitro models to explore the mechanisms of action and interactions of nanoformulations with the molecular mediators of oxidative/nitrosative stress caused by osteoarthritic pain conditions.
Specific topics covered by this Special Issue include:
- Basic and applied osteoarthritic pain research.
- Multidisciplinary osteoarthritic pain research.
- Osteoarthritis and comorbidities.
- Drug studies involve the treatment of osteoarthritis.
- Genetics in osteoarthritis.
- Molecular mechanisms of osteoarthritis and associated pain.
Dr. Gurjit Singh
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- osteoarthritis
- pain
- cartilage degeneration
- molecular pain pathway
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
